← Leaderboards
Laurence Huang
University Of California San Francisco
$20,236,114
Attributed
$38,755,347
Total exposure
10
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.5M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$38,755,347 · 10
By mechanism
R01$16,200,573 · 5
T32$14,548,629 · 1
U01$3,903,734 · 1
K24$1,836,629 · 1
K12$1,779,350 · 1
K23$486,432 · 1
Top collaborators
- Dean Sheppard14 shared
- David J Erle9 shared
- Peter W Hunt9 shared
- Priscilla Y. Hsue8 shared
- Jue Lin8 shared
- Prescott G Woodruff7 shared
- Susan Veronica Lynch6 shared
- Jay Nadel5 shared
Most similar at University Of California San Francisco
Same institution · by research overlap
- John E Conte$521,293
- Prescott G Woodruff$62,639,366
Others in their field
Top investigators on “Lung Diseases”
- Chanza Baytop · Westat, Inc.$271,217,917
- David Heimbrook · Leidos Biomedical Research, Inc.$251,056,084
- Richard K. Wilson · Washington University$201,818,043
- Richard C Boucher · University Of North Carolina Chapel Hill$113,731,309
- James D Crapo · University Of Colorado Denver$90,634,881
- Rebecca Montalvan · Westat, Inc.$86,600,000
Research focus
Lung DiseasesPneumoniaCohortPersonsUgandaEnrollmentFutureInternationalLungSan FranciscoMorbidity - Disease RateHiv InfectionsPathway InteractionsSpirometryChronicAcuteFoundationsSpecimenBloodMicrobeSamplingBronchoalveolar LavageBiological MarkersMortality
Grant awards (68)
Multidisciplinary Training Program in Lung Disease$1,316,196
T32 · FY2025 · HL
Sex, HIV, and Air Pollution Effects on Post-TB Lung Disease (SHAPE PTLD)$561,226
R01 · FY2025 · HL · contact PI
Heart and Lung Outcomes Post-TB (HALO Post-TB)$388,131
R01 · FY2025 · HL
Heart and Lung Outcomes Post-TB (HALO Post-TB)$212,175
R01 · FY2025 · HL
Sex, HIV, and Air Pollution Effects on Post-TB Lung Disease (SHAPE PTLD)$148,676
R01 · FY2025 · HL · contact PI
Multidisciplinary Training Program in Lung Disease$1,331,043
T32 · FY2024 · HL
Inflammation, Aging, Microbes, Obstructive Lung Disease and Diffusion Abnormalities (I AM OLD-DA) Study$751,857
R01 · FY2024 · HL · contact PI
Heart and Lung Outcomes Post-TB (HALO Post-TB)$625,859
R01 · FY2024 · HL
Multidisciplinary Training Program in Lung Disease$1,254,303
T32 · FY2023 · HL
Inflammation, Aging, Microbes, Obstructive Lung Disease and Diffusion Abnormalities (I AM OLD-DA) Study$750,252
R01 · FY2023 · HL · contact PI
Inflammation, Aging, Microbes, Obstructive Lung Disease and Diffusion Abnormalities (I AM OLD-DA) Study$53,069
R01 · FY2023 · HL · contact PI
Multidisciplinary Training Program in Lung Disease$1,243,626
T32 · FY2022 · HL
Integrated Analysis of Microbial and Genomic data in Obstructive Lung Disease (I AM GOLD) Study$752,810
R01 · FY2022 · HL · contact PI
Inflammation, Aging, Microbes, Obstructive Lung Disease and Diffusion Abnormalities (I AM OLD-DA) Study$750,787
R01 · FY2022 · HL · contact PI
UCSF Career Development Program in Cardiopulmonary, Hematologic, and Immunologic Comorbidities of HIV (CHIC)$419,849
K12 · FY2022 · HL · contact PI
Inflammation, Aging, Microbes, Obstructive Lung Disease, and Diffusion Abnormalities (I AM OLD-DA): Pulmonary function in females, evaluating the menopausal transition and immune activation (pFEMI).$159,182
R01 · FY2022 · HL · contact PI
Inflammation, Aging, Microbes, Obstructive Lung Disease and Diffusion Abnormalities (I AM OLD-DA) Study$91,667
R01 · FY2022 · HL · contact PI
Inflammation, Aging, Microbes, Obstructive Lung Disease and Diffusion Abnormalities (I AM OLD-DA) Study - Diversity Supplement$38,599
R01 · FY2022 · HL · contact PI
Multidisciplinary Training Program in Lung Disease$838,264
T32 · FY2021 · HL
Integrated Analysis of Microbial and Genomic data in Obstructive Lung Disease (I AM GOLD) Study$752,810
R01 · FY2021 · HL · contact PI
Inflammation, Aging, Microbes, Obstructive Lung Disease and Diffusion Abnormalities (I AM OLD-DA) Study$749,503
R01 · FY2021 · HL · contact PI
UCSF Career Development Program in Cardiopulmonary, Hematologic, and Immunologic Comorbidities of HIV (CHIC)$419,849
K12 · FY2021 · HL · contact PI
Integrated Analysis of Microbial and Genomic data in Obstructive Lung Disease (I AM GOLD) Study$89,962
R01 · FY2021 · HL · contact PI
Multidisciplinary Training Program in Lung Disease$1,161,132
T32 · FY2020 · HL
Inflammation, Aging, Microbes, Obstructive Lung Disease and Diffusion Abnormalities (I AM OLD-DA) Study$755,040
R01 · FY2020 · HL · contact PI
Integrated Analysis of Microbial and Genomic data in Obstructive Lung Disease (I AM GOLD) Study$752,810
R01 · FY2020 · HL · contact PI
UCSF Career Development Program in Cardiopulmonary, Hematologic, and Immunologic Comorbidities of HIV (CHIC)$419,849
K12 · FY2020 · HL · contact PI
Enhancing the I AM GOLD study with single-cell deep phenotyping and machine learning meta-analysis$89,962
R01 · FY2020 · HL · contact PI
Multidisciplinary Training Program in Lung Disease$1,109,184
T32 · FY2019 · HL
Integrated Analysis of Microbial and Genomic data in Obstructive Lung Disease (I AM GOLD) Study$774,747
R01 · FY2019 · HL · contact PI
UCSF Career Development Program in Cardiopulmonary, Hematologic, and Immunologic Comorbidities of HIV (CHIC)$419,849
K12 · FY2019 · HL · contact PI
Multidisciplinary Training Program in Lung Disease$1,073,074
T32 · FY2018 · HL
Inflammation, Aging, Microbes, and Obstructive Lung Disease (I AM OLD) Study$722,915
R01 · FY2018 · HL · contact PI
Patient-Oriented Research and Mentoring in HIV-associated Pulmonary Diseases$181,443
K24 · FY2018 · HL · contact PI
UCSF Career Development Program in Cardiopulmonary, Hematologic, and Immunologic Comorbidities of HIV (CHIC)$99,954
K12 · FY2018 · HL · contact PI
Multidisciplinary Training Program in Lung Disease$1,043,093
T32 · FY2017 · HL
Inflammation, Aging, Microbes, and Obstructive Lung Disease (I AM OLD) Study$728,630
R01 · FY2017 · HL · contact PI
Patient-Oriented Research and Mentoring in HIV-associated Pulmonary Diseases$181,443
K24 · FY2017 · HL · contact PI
Multidisciplinary Training Program in Lung Disease$782,132
T32 · FY2016 · HL
Inflammation, Aging, Microbes, and Obstructive Lung Disease (I AM OLD) Study$734,748
R01 · FY2016 · HL · contact PI
Patient-Oriented Research and Mentoring in HIV-associated Pulmonary Diseases$181,443
K24 · FY2016 · HL · contact PI
Multidisciplinary Training Program in Lung Disease$879,894
T32 · FY2015 · HL
Inflammation, Aging, Microbes, and Obstructive Lung Disease (I AM OLD) Study$777,563
R01 · FY2015 · HL · contact PI
Patient-Oriented Research and Mentoring in HIV-associated Pulmonary Diseases$181,443
K24 · FY2015 · HL · contact PI
Multidisciplinary Training Program in Lung Disease$797,037
T32 · FY2014 · HL
Patient-Oriented Research and Mentoring in HIV-associated Pulmonary Diseases$181,443
K24 · FY2014 · HL · contact PI
Multidisciplinary Training Program in Lung Disease$915,745
T32 · FY2013 · HL
Lung Microbiome in Cohorts of HIV-Infected Persons (Lung MicroCHIP) Study$694,210
U01 · FY2013 · HL · contact PI
Multidisciplinary Training Program in Lung Disease$803,906
T32 · FY2012 · HL
Lung Microbiome in Cohorts of HIV-Infected Persons (Lung MicroCHIP) Study$797,269
U01 · FY2012 · HL · contact PI
Lung Microbiome in Cohorts of HIV-Infected Persons (Lung MicroCHIP) Study$800,042
U01 · FY2011 · HL · contact PI
International HIV-associated Opportunistic Pneumonias (IHOP) Study$743,443
R01 · FY2011 · HL · contact PI
Lung Microbiome in Cohorts of HIV-Infected Persons (Lung MicroCHIP) Study$805,749
U01 · FY2010 · HL · contact PI
International HIV-associated Opportunistic Pneumonias (IHOP) Study$728,931
R01 · FY2010 · HL · contact PI
Patient-Oriented Research and Mentoring in Pneumocystis$169,936
K24 · FY2010 · HL · contact PI
Lung Microbiome in Cohorts of HIV-Infected Persons (Lung MicroCHIP) Study$806,464
U01 · FY2009 · HL · contact PI
International HIV-associated Opportunistic Pneumonias (IHOP) Study$734,306
R01 · FY2009 · HL · contact PI
International HIV-associated Opportunistic Pneumonias (IHOP) Study$258,800
R01 · FY2009 · HL · contact PI
Patient-Oriented Research and Mentoring in Pneumocystis$169,937
K24 · FY2009 · HL · contact PI
International HIV-associated Opportunistic Pneumonias (IHOP) Study$740,203
R01 · FY2008 · HL · contact PI
Patient-Oriented Research and Mentoring in Pneumocystis$169,936
K24 · FY2008 · HL · contact PI
International HIV-associated Opportunistic Pneumonias (IHOP) Study$781,910
R01 · FY2007 · HL · contact PI
Patient-Oriented Research and Mentoring in Pneumocystis$211,540
K24 · FY2007 · HL · contact PI
Patient-Oriented Research and Mentoring in Pneumocystis$208,065
K24 · FY2006 · HL · contact PI
Molecular Epidemiology of Human P. carinii Pneumonia$121,608
K23 · FY2006 · HL · contact PI
Molecular Epidemiology of Human P. carinii Pneumonia$121,608
K23 · FY2005 · HL
Molecular Epidemiology of Human P. carinii Pneumonia$121,608
K23 · FY2004 · HL
Molecular Epidemiology of Human P. carinii Pneumonia$121,608
K23 · FY2003 · HL